China Universal Asset Management Company’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
BTW
PCM
ACM
WCM
PL
China Universal Asset Management Company's JAZZ Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Jazz Pharmaceuticals (JAZZ) stake by 8.6% in Q2 2026, selling an estimated $205K and leaving 9,986 shares worth $2.41M. The position accounts for 0.14% of the portfolio, ranked #110.
China Universal Asset Management Company first reported a position in JAZZ in Q3 2022 and has held it in 16 quarters since. 213 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- China Universal Asset Management Company held 9,986 shares of Jazz Pharmaceuticals worth $2.41M as of Q2 2026.
- China Universal Asset Management Company sold 938 Jazz Pharmaceuticals shares in Q2 2026, an estimated $205K.
- Jazz Pharmaceuticals made up 0.14% of China Universal Asset Management Company's portfolio in Q2 2026, its #110 holding.
- China Universal Asset Management Company first reported a position in Jazz Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- 213 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.